Literature DB >> 32211842

Comparing Methods to Determine the Minimal Clinically Important Differences in Patient-Reported Outcome Measures for Veterans Undergoing Elective Total Hip or Knee Arthroplasty in Veterans Health Administration Hospitals.

Alfred C Kuo1,2, Nicholas J Giori3, Thomas R Bowe4, Luisa Manfredi4, Narlina F Lalani5, David A Nordin5, Alex H S Harris4.   

Abstract

Importance: The minimal clinically important difference (MCID) in a patient-reported outcome measure (PROM) is the smallest change that patients perceive as beneficial. Accurate MCIDs are required when PROMs are used to evaluate the value of surgical interventions. Objective: To use well-defined distribution-based and anchor-based methods to calculate MCIDs in the Hip Disability and Osteoarthritis Outcome Score (HOOS) and in the Knee Injury and Osteoarthritis Outcome Score (KOOS) for veterans undergoing primary total hip arthroplasty or total knee arthroplasty. Design, Setting, and Participants: A prospective cohort study was conducted of 858 patients undergoing total joint replacement between March 16, 2015, and March 9, 2017, at 3 high-complexity Veterans Affairs Medical Centers. Interventions: Patients undergoing total hip arthroplasty or total knee arthroplasty were administered HOOS or KOOS PROMs prior to and 1 year after surgery. The Self-Administered Patient Satisfaction Scale (SAPS) for primary hip or knee arthroplasty was administered at 1-year follow-up as an anchor PROM. Main Outcomes and Measures: The HOOS and KOOS before and 1 year after surgery, change scores (difference between postoperative and preoperative PROM scores), and MCIDs for each measure. For anchor-based methods, receiver operating characteristic curve analysis was performed, including calculation of the area under the curve.
Results: The mean (SD) age of the 271 patients who underwent hip arthroplasty was 65.6 (8.3) years, and the mean (SD) age of the 587 patients who underwent knee arthroplasty was 66.1 (8.2) years. There were 547 men in the knee arthroplasty cohort and 256 men in the hip arthroplasty cohort (total, 803 men). There were significant improvements in the mean values of every PROM, with mean (SD) differences greater than 39 for HOOS Joint Replacement (JR) and every hip subscale (HOOS JR, 39.7 [20.2]; pain, 47.6 [20.5]; symptoms, 45.1 [21.5]; activities of daily living, 43.7 [22.1]; recreation, 49.2 [33.5]; quality of life, 50.3 [27.8]) and mean (SD) differences greater than 29 for KOOS JR and every knee subscale (KOOS JR, 30.4 [17.5]; pain, 38.0 [20.4]; symptoms, 29.5 [22.1]; activities of daily living, 34.8 [20.5]; recreation, 34.6 [31.1]; quality of life, 35.2 [26.8]). Different calculation methods yielded a wide range of MCIDs. Distribution-based approaches tended to give lower values than the anchor-based approaches, which gave similar values for most PROMs. Area under the curve values demonstrated good to excellent discrimination for SAPS for nearly all PROMs. Conclusions and Relevance: Minimal clinically important difference estimates can be highly variable depending on the method used. Patient satisfaction measured by SAPS is a suitable anchor for the HOOS and KOOS. This study suggests that the SAPS-anchored MCID values presented here be used in future studies of total hip arthroplasty and total knee arthroplasty for veterans.

Entities:  

Year:  2020        PMID: 32211842      PMCID: PMC7097846          DOI: 10.1001/jamasurg.2020.0024

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  20 in total

Review 1.  Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Authors:  Geoffrey R Norman; Jeff A Sloan; Kathleen W Wyrwich
Journal:  Med Care       Date:  2003-05       Impact factor: 2.983

2.  Do Veterans Health Administration Enrollees Generalize to Other Populations?

Authors:  Edwin S Wong; Virginia Wang; Chuan-Fen Liu; Paul L Hebert; Matthew L Maciejewski
Journal:  Med Care Res Rev       Date:  2015-11-20       Impact factor: 3.929

3.  The Association of Patient Satisfaction with Pain, Anxiety, and Self-Reported Physical Function.

Authors:  Andrew R Tyser; Christian J Gaffney; Chong Zhang; Angela P Presson
Journal:  J Bone Joint Surg Am       Date:  2018-11-07       Impact factor: 5.284

4.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

5.  Minimum Clinically Important Difference: Current Trends in the Orthopaedic Literature, Part I: Upper Extremity: A Systematic Review.

Authors:  Anne G Copay; Andrew S Chung; Blake Eyberg; Neil Olmscheid; Norman Chutkan; Mark J Spangehl
Journal:  JBJS Rev       Date:  2018-09

6.  What Are the Minimal and Substantial Improvements in the HOOS and KOOS and JR Versions After Total Joint Replacement?

Authors:  Stephen Lyman; Yuo-Yu Lee; Alexander S McLawhorn; Wasif Islam; Catherine H MacLean
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

7.  Observations from the national implementation of Measurement Based Care in Mental Health in the Department of Veterans Affairs.

Authors:  Sandra G Resnick; Rani A Hoff
Journal:  Psychol Serv       Date:  2019-05-06

8.  Hip disability and osteoarthritis outcome score. An extension of the Western Ontario and McMaster Universities Osteoarthritis Index.

Authors:  Maria Klässbo; Eva Larsson; Eva Mannevik
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

9.  John Charnley Award: Preoperative Patient-reported Outcome Measures Predict Clinically Meaningful Improvement in Function After THA.

Authors:  Jonathan L Berliner; Dane J Brodke; Vanessa Chan; Nelson F SooHoo; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

10.  Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively.

Authors:  Aksel Paulsen; Ewa M Roos; Alma B Pedersen; Søren Overgaard
Journal:  Acta Orthop       Date:  2013-11-29       Impact factor: 3.717

View more
  6 in total

1.  What Is the Clinical Benefit of Common Orthopaedic Procedures as Assessed by the PROMIS Versus Other Validated Outcomes Tools?

Authors:  Aditya V Karhade; David N Bernstein; Vineet Desai; Hany S Bedair; Evan A O'Donnell; Miho J Tanaka; Christopher M Bono; Mitchel B Harris; Joseph H Schwab; Daniel G Tobert
Journal:  Clin Orthop Relat Res       Date:  2022-05-10       Impact factor: 4.755

2.  Equivalent outcomes of ultra-congruent and standard cruciate-retaining inserts in total knee arthroplasty.

Authors:  Karthik Vishwanathan; Srinivas B S Kambhampati; Raju Vaishya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-01-11       Impact factor: 4.114

3.  A Psycholgical Intervention Delivered by Automated Mobile Phone Messaging Stabilized Hip and Knee Function During the COVID-19 Pandemic: A Randomized Controlled Trial.

Authors:  Chris A Anthony; Edward Rojas; Natalie Glass; Valerie Keffala; Nicholas Noiseux; Jacob Elkins; Timothy S Brown; Nicholas A Bedard
Journal:  J Arthroplasty       Date:  2021-12-11       Impact factor: 4.757

4.  Deconstructing the Minimum Clinically Important Difference (MCID).

Authors:  Janine Molino; Joseph Harrington; Jennifer Racine-Avila; Roy Aaron
Journal:  Orthop Res Rev       Date:  2022-02-17

5.  Patient-reported outcome after primary and aseptic revision hip arthroplasty: 1-year follow-up of 3,559 primary and 406 revision THAs in an institutional registry.

Authors:  Tina S Wik; Jomar Klaksvik; Otto S Husby; Astrid Rasch; Siri B Winther
Journal:  Acta Orthop       Date:  2022-01-03       Impact factor: 3.717

6.  Effects of Protein Supplementation Combined with Exercise Training on Muscle Mass and Function in Older Adults with Lower-Extremity Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Chun-De Liao; Yen-Tzu Wu; Jau-Yih Tsauo; Pey-Rong Chen; Yu-Kang Tu; Hung-Chou Chen; Tsan-Hon Liou
Journal:  Nutrients       Date:  2020-08-12       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.